Elevated interleukin-1β in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis

References

• Rebuffat SA, Kammoun-Krichen M, Charfeddine I, et al. IL-1beta and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases. Immunobiology 2013;218(3):285–91.
   PubMed Web of Science ®Google Scholar
• Wiersinga WM. Thyroid autoimmunity. Endocr Dev 2014;26:139–57.
   PubMedGoogle Scholar
• Tamai H, Kasagi K, Takaichi Y, et al. Development of spontaneous hypothyroidism in patients with Graves’ disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 1989;69(1):49–53.
   PubMed Web of Science ®Google Scholar
• Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol/Eur Fed Endocr Soc 2003;148(1):1–9.
   PubMed Web of Science ®Google Scholar
• Mine M, Tramontano D, Chin WW, Ingbar SH. Interleukin-1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture. Endocrinology 1987;120(3):1212–4.
   PubMed Web of Science ®Google Scholar
• Enomoto T, Sugawa H, Kosugi S, et al. Prolonged effects of recombinant human interleukin-1 alpha on mouse thyroid function. Endocrinology 1990;127(5):2322–7.
   PubMed Web of Science ®Google Scholar
• Diamant M, Kayser L, Rasmussen AK, et al. Interleukin-6 production by thyroid epithelial cells. Enhancement by interleukin-1. Autoimmunity 1991;11(1):21–6.
   PubMed Web of Science ®Google Scholar
• Weetman AP, Bennett GL, Wong WL. Thyroid follicular cells produce interleukin-8. J Clin Endocrinol Metab 1992;75(1):328–30.
   PubMed Web of Science ®Google Scholar
• Nilsson M, Husmark J, Bjorkman U, Ericson LE. Cytokines and thyroid epithelial integrity: interleukin-1alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 1998;83(3):945–52.
   PubMed Web of Science ®Google Scholar
• Rasmussen AK, Feldt-Rasmussen U, Bendtzen K. The effect of interleukin-1 on the thyroid gland. Autoimmunity 1993;16(2):141–8.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Kimura H, Ashizawa K, et al. Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J Endocrinol 1989;122(1):177–83.
   PubMed Web of Science ®Google Scholar
• Ashizawa K, Yamashita S, Tobinaga T, et al. Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol 1989;121(4):465–9.
   PubMedGoogle Scholar
• Sato K, Satoh T, Shizume K, et al. Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990;70(6):1735–43.
   PubMed Web of Science ®Google Scholar
• Ajjan RA, Watson PF, Findlay C, et al. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol 1998;158(3):351–8.
   PubMed Web of Science ®Google Scholar
• Wewers MD, Dare HA, Winnard AV, et al. IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent. J Immunol 1997;159(12):5964–72. ( Baltimore, MD: 1950).
   PubMed Web of Science ®Google Scholar
• Rosenwasser LJ. Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 1998;102(3):344–50.
   PubMed Web of Science ®Google Scholar
• Li Y, Yu Y, Zhang Y, et al. MAFIP is a tumor suppressor in cervical cancer that inhibits activation of the nuclear factor-kappa B pathway. Cancer Sci 2011;102(11):2043–50.
   PubMed Web of Science ®Google Scholar
• Beumer W, Effraimidis G, Drexhage RC, et al. Changes in serum adhesion molecules, chemokines, cytokines, and tissue remodeling factors in euthyroid women without thyroid antibodies who are at risk for autoimmune thyroid disease: a hypothesis on the early phases of the endocrine autoimmune reaction. J Clin Endocrinol Metab 2013;98(6):2460–8.
   PubMed Web of Science ®Google Scholar
• Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science 1997;275(5302):960–3.
   PubMed Web of Science ®Google Scholar
• Kammoun-Krichen M, Bougacha-Elleuch N, Mnif M, et al. IL-1beta a potential factor for discriminating between thyroid carcinoma and atrophic thyroiditis. Eur Cytokine Netw 2012;23(3):101–6.
   PubMed Web of Science ®Google Scholar
• Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid Off J Am Thyroid Assoc 2003;13(1):3–126.
   PubMed Web of Science ®Google Scholar
• Baldane S, Ipekci SH, Kebapcilar L. Immunosuppressive treatment for immune thrombocytopenia which masked Graves’ disease. J Family Med Primary Care 2015;4(2):276–7.
   PubMedGoogle Scholar
• Klatka M, Grywalska E, Partyka M, et al. Th17 and Treg cells in adolescents with Graves’ disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity 2014;47(3):201–11.
   PubMed Web of Science ®Google Scholar
• Baccarelli A, Giacomini SM, Corbetta C, et al. Neonatal thyroid function in Seveso 25 years after maternal exposure to dioxin. PLoS Med 2008;5(7):e161.
   PubMed Web of Science ®Google Scholar
• Pavuk M, Schecter AJ, Akhtar FZ, Michalek JE. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) levels and thyroid function in Air Force veterans of the Vietnam War. Ann Epidemiol 2003;13(5):335–43.
   PubMed Web of Science ®Google Scholar
• Zhao R, Zhou H, Su SB. A critical role for interleukin-1beta in the progression of autoimmune diseases. Int Immunopharmacol 2013;17(3):658–69.
   PubMed Web of Science ®Google Scholar